| Display title | Company:Metascreen |
| Default sort key | Metascreen |
| Page length (in bytes) | 7,044 |
| Namespace ID | 3042 |
| Namespace | Company |
| Page ID | 856000 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MedAI |
| Date of page creation | 21:05, 27 June 2023 |
| Latest editor | imported>MedAI |
| Date of latest edit | 21:05, 27 June 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Metascreen is an advanced non-invasive metabolic screening test distributed by Cordlife Group Limited ("Cordlife"). It can detect as many as 110 inborn errors of metabolism ("IEMs", or metabolic disorders) from a urine specimen. Cordlife owns the brand name and trademark, "Metascreen". |
